TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Pharmalex Norway AS
Closing information (x1000 DKK)
Closing information | 2023/09 | 2022/12 | 2021/12 |
Turnover |
13,846
|
20,254
|
17,100 |
Financial expenses |
365
|
548
|
385 |
Earnings before taxes |
87
|
3,204
|
3,996 |
Total assets |
4,641
|
8,135
|
8,348 |
Current assets |
4,592
|
7,904
|
8,144 |
Current liabilities |
2,282
|
5,688
|
5,787 |
Equity capital |
2,358
|
2,446
|
2,560 |
- share capital |
66
|
71
|
75 |
Financial ratios
Fiscal year | 2023/09 | 2022/12 | 2021/12 |
Solvency |
50.8%
|
30.1%
|
30.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
0.6%
|
15.8%
|
23.4% |
Return on assets (ROA) |
9.7%
|
46.1%
|
52.5% |
Current ratio |
201.2%
|
139.0%
|
140.7% |
Return on equity (ROE) |
3.7%
|
131.0%
|
156.1% |
Change turnover |
-5,131
|
4,052
|
6,592 |
Change turnover % |
-27%
|
25%
|
63% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/09 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.